Related Experiment Videos
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Jamaica
Insights
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in sickle cell disease patients showed no significant impact on disease severity or specific blood markers. However, higher G6PD deficiency prevalence was noted in younger patients.
Area of Science:
- Genetics
- Hematology
- Biochemistry
Background:
- Sickle cell disease (SCD) is a genetic blood disorder with significant morbidity.
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited enzyme disorder.
- Investigating the interaction between G6PD deficiency and SCD is crucial for understanding disease pathophysiology.
Purpose of the Study:
- To examine the relationship between G6PD deficiency and homozygous sickle cell (SS) disease.
- To assess if G6PD deficiency influences clinical severity or hematological parameters in SCD patients.
Main Methods:
- Studied 120 patients with homozygous sickle cell disease.
- Assessed G6PD status (hemizygotes, heterozygotes, homozygotes).
- Compared G6PD status prevalence with general population expectations and across different age groups.
Main Results:
- No significant difference in G6PD status proportions compared to expected in the general population.
- A significantly higher proportion of patients with abnormal G6PD status was observed in the 10-19 years age group compared to the 20-29 years age group.
- No correlation found between G6PD status and total hemoglobin, reticulocyte count, bilirubin, Hb F, irreversibly sickled cells, plasma hemoglobin, clinical severity, or leg ulceration.
Conclusions:
- G6PD deficiency does not significantly alter the clinical course or hematological profile of homozygous sickle cell disease.
- The increased prevalence of G6PD deficiency in younger SCD patients warrants further investigation.
- G6PD status is not a determinant of disease severity or complications in this cohort.
Abstract:
The relationship between D-glucose-6-phosphate: NADP oxido-reductase (E.C.1.1.1.49; glucose-6-phosphate dehydrogenase; G6PD) deficiency and homozygous sickle cell (SS) disease was examined in 120 patients. The proportions of hemizygotes (22.6%) was slightly more than that observed, and the combined proportions of heterozygotes and homozygotes (28.3%) were slightly less than would be expected, in the general population, but the differences were not significant. However, the proportion of patients of abnormal G6PD status in the 10-19 years age group was 41.7%, significantly more than that found in the 20-29 years age group (0.02 less than P less than 0.05), or expected in the general population (P=0.05). Possible reasons for this are discussed. Difference in G6PD status did not affect the total haemoglobin concentration, reticulocyte count, unconjugated serum bilirubin or Hb F concentration, irreversibly sickled cell counts or plasma haemoglobin concentration, and there was no demonstrable correlation between clinical severity or leg ulceration and abnormal G6PD status.